$333.73
Value $129B
ETN and SRTA stock compared: price, dividend, valuation and results, from SEC filings.
$333.73
Value $129B
$5.33
Value $464M
Eaton (ETN) has a market value of $129B and Strata Critical Medical (SRTA) $464M. Over the last year, with dividends, ETN moved -4.2% and SRTA +11.5%. Dividend yield: ETN 1.32%, SRTA none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ETN$129B
SRTA$464M
ETN is 279 times SRTA
Revenue, 12 months
ETN$32.0B
SRTA$281M
ETN is 114 times SRTA
Net income, 12 months
ETN$3.9B
SRTA-$25M
Operating margin
ETN–
SRTA-6.6%
ROIC
ETN10.8%
SRTA-5.2%
16.0 points apart
P/E
ETN33.2
SRTA–
Dividend yield
ETN1.3%
SRTA0.0%
1.3 points apart
5-year return
ETN+107.2%
SRTA-50.8%
158.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ETN+107.2%
SRTA-50.8%
| Period | ETNWith dividends | SRTAWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | -4.2%Price -5.3% | +11.5%Price +11.5% |
| 3 years since November 17, 2023 | +51.9%+15.0% a yearPrice +46.5% | +49.2%+14.3% a yearPrice +49.2% |
| 5 years since November 16, 2021 | +107.2%+15.7% a yearPrice +92.0% | -50.8%-13.2% a yearPrice -50.8% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ETNEatonSRTAStrata Critical Medical
| Price | $333.73 | $5.33 |
|---|---|---|
| Market value | $129B | $464M |
| Enterprise value (EV) | $148B | $422M |
| P/E | 33.2 | – |
| P/E, 5-year median | 30.5 | – |
| P/B | 6.2 | 1.7 |
| EV/EBIT | 30.1 | – |
| Free cash flow yield | 2.9% | 0.2% |
| Revenue, 12 months | $32.0B | $281M |
|---|---|---|
| Net income, 12 months | $3.9B | -$25M |
| Free cash flow, 12 months | $3.8B | $806.0K |
| Earnings per share, 12 months | $10.01 | -$0.30 |
| Revenue growth, year on year | 10.3% | 34.3% |
| Revenue growth a year, past | +9.0%over 5 years | +53.1%over 5 years |
| EPS growth a year, past | +24.5%over 5 years | – |
| Gross margin | 35.1% | 21.6% |
|---|---|---|
| Operating margin | – | -6.6% |
| Net margin | 12.2% | -8.8% |
| ROIC | 10.8% | -5.2% |
| ROE | 19.6% | -8.8% |
| Cash | $818M | $42M |
|---|---|---|
| Total debt | $20.2B | $3.6M |
| Net debt / EBITDA | 3.1 | – |
| Interest cover | 8.6× | – |
| Dividend yield | 1.3% | – |
|---|---|---|
| Dividend per share, 12 months | $4.40 | – |
| Dividend growth a year, past | +7.3%over 5 years | – |
| Buyback yield | 1.4% | – |
| Shareholder yield | 2.8% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Eaton ($129B) is about 278.9 times Strata Critical Medical ($464M), at today's prices.
Since November 16, 2021, ETN's price moved +92.0% and SRTA's -50.8%. With dividends: ETN +107.2% (+15.7% a year), SRTA -50.8% (-13.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.32% for Eaton and none for Strata Critical Medical. Over the last twelve months they paid $4.40 and – per share.
Over the last twelve months, the net margin was 12.2% for Eaton and -8.8% for Strata Critical Medical, and the operating margin – and -6.6%. Revenue was $32.0B and $281M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.